MDAI · Spectral AI Inc. Class A Common Stock
View on chartInsiders & Stakes
| John Michael DiMaio Director | ▲ Buy | Grant | 2,922,847 Shares held | 9/28/2026 | View profile |
| GLAZER CAPITAL, LLC 10% Owner | ▼ Sell | Open Market | 2,512,808 Shares held | 5/21/2021 | View profile |
| Rosecliff Acquisition Sponsor I LLC Director | ▲ Buy | Grant | 848,333 Shares held | 9/11/2023 | View profile |
| Erich Spangenberg Director | ▲ Buy | Grant | 628,574 Shares held | 5/15/2024 | View profile |
| Vincent S. Capone GENERAL COUNSEL | ▲ Buy | Grant | 286,450 Shares held | 4/24/2026 | View profile |
| Wensheng Fan CHIEF EXECUTIVE OFFICER | ▼ Sell | Other | 145,489 Shares held | 9/11/2023 | View profile |
| Richard John Cotton Director | ▲ Buy | Grant | 111,477 Shares held | 5/18/2026 | View profile |
| Peter M. Carlson Director | ▲ Buy | Grant | 29,411 Shares held | 5/10/2024 | View profile |
| Brian J. Radecki Director | ▲ Buy | Option Exercise | 25,000 Shares held | 9/11/2023 | View profile |
| Deepak Sadagopan Director | ▲ Buy | Grant | 25,000 Shares held | 4/24/2026 | View profile |
| Marion Ann Snyder Director | ▲ Buy | Grant | 25,000 Shares held | 4/24/2026 | View profile |
| Martin C.B. Mellish Director | ▲ Buy | Grant | 24,398 Shares held | 6/4/2025 | View profile |
| Jeffrey Edward Thatcher CHIEF SCIENTIST | ▼ Sell | Other | 23,278 Shares held | 9/11/2023 | View profile |
| Heather Bellini Director | ▲ Buy | Option Exercise | 20,000 Shares held | 9/11/2023 | View profile |
| Franklin S. Edmonds Jr. Director | ▲ Buy | Option Exercise | 20,000 Shares held | 9/11/2023 | View profile |
| Jeremiah A. Sparks Chief Commerical Officer | ▲ Buy | Grant | 16,084 Shares held | 5/10/2024 | View profile |
| Stan Micek CHIEF OPERATING OFFICER | ▲ Buy | Grant | 10,000 Shares held | 5/10/2024 | View profile |
Transaction History
| John Michael DiMaio | ▲ Buy | Grant | 32,000 | $52K | 9/28/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 60,000 | $100K | 9/23/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 21,012 | $36K | 9/21/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 10,988 | $18K | 9/18/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 22,000 | $35K | 9/11/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 10,000 | $16K | 9/10/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 35,000 | $57K | 8/13/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 15,000 | $26K | 6/29/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 14,700 | $25K | 6/25/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 14,300 | $25K | 6/24/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 15,000 | $32K | 5/29/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 2,500 | $6K | 5/28/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 32,233 | $84K | 5/26/2026 |
| Richard John Cotton | ▲ Buy | Grant | 8,818 | $21K | 5/18/2026 |
| Richard John Cotton | ▲ Buy | Grant | 5,882 | $14K | 5/15/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 1,887 | $4K | 5/15/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 25,000 | $54K | 5/15/2026 |
| Deepak Sadagopan | ▲ Buy | Grant | 25,000 | $0 | 4/24/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 100,000 | $0 | 4/24/2026 |
| Richard John Cotton | ▲ Buy | Grant | 29,850 | $0 | 4/24/2026 |
| Marion Ann Snyder | ▲ Buy | Grant | 25,000 | $0 | 4/24/2026 |
| Vincent S. Capone | ▲ Buy | Grant | 100,000 | $0 | 4/24/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 7,619 | $12K | 3/27/2026 |
| Vincent S. Capone | ▲ Buy | Grant | 16,750 | $25K | 3/27/2026 |
| John Michael DiMaio | ▲ Buy | Grant | 9,700 | $20K | 6/10/2025 |
| John Michael DiMaio | ▲ Buy | Grant | 2,000 | $4K | 6/9/2025 |
| Martin C.B. Mellish | ▲ Buy | Grant | 5,000 | $9K | 6/4/2025 |
| Richard John Cotton | ▲ Buy | Grant | 9,699 | $0 | 4/30/2025 |
| Martin C.B. Mellish | ▲ Buy | Grant | 9,699 | $0 | 4/30/2025 |
| Vincent S. Capone | ▲ Buy | Grant | 100,000 | $0 | 4/30/2025 |
| Erich Spangenberg | ▲ Buy | Grant | 6,000 | $10K | 5/15/2024 |
| John Michael DiMaio | ▲ Buy | Open Market | 6,000 | $10K | 5/10/2024 |
| Vincent S. Capone | ▲ Buy | Grant | 10,000 | $17K | 5/10/2024 |
| Stan Micek | ▲ Buy | Grant | 10,000 | $17K | 5/10/2024 |
| Peter M. Carlson | ▲ Buy | Grant | 29,411 | $51K | 5/10/2024 |
| Erich Spangenberg | ▲ Buy | Grant | 45,000 | $80K | 5/10/2024 |
| Jeremiah A. Sparks | ▲ Buy | Grant | 6,084 | $10K | 5/10/2024 |
| John Michael DiMaio | ▼ Sell | Other | 2,000 | $4K | 1/19/2024 |
| John Michael DiMaio | ▼ Sell | Other | 2,000 | $5K | 1/9/2024 |
| John Michael DiMaio | ▲ Buy | Open Market | 2,000 | $5K | 11/20/2023 |
| Richard John Cotton | ▲ Buy | Grant | 14,650 | $39K | 11/17/2023 |
| John Michael DiMaio | ▲ Buy | Open Market | 500 | $1K | 11/16/2023 |
| John Michael DiMaio | ▲ Buy | Open Market | 355 | $998 | 11/14/2023 |
| John Michael DiMaio | ▲ Buy | Open Market | 198 | $1K | 9/13/2023 |
| John Michael DiMaio | ▲ Buy | Open Market | 1,000 | $6K | 9/12/2023 |
| Vincent S. Capone | ▼ Sell | Other | 9,699 | — | 9/11/2023 |
| Brian J. Radecki | ▲ Buy | Option Exercise | 25,000 | $0 | 9/11/2023 |
| Franklin S. Edmonds Jr. | ▲ Buy | Option Exercise | 20,000 | $0 | 9/11/2023 |
| Rosecliff Acquisition Sponsor I LLC | ▲ Buy | Option Exercise | 815,000 | $0 | 9/11/2023 |
| Rosecliff Acquisition Sponsor I LLC | ▲ Buy | Grant | 33,333 | $0 | 9/11/2023 |
| Jeffrey Edward Thatcher | ▼ Sell | Other | 23,278 | — | 9/11/2023 |
| Heather Bellini | ▲ Buy | Option Exercise | 20,000 | $0 | 9/11/2023 |
| Wensheng Fan | ▼ Sell | Other | 145,489 | — | 9/11/2023 |
| Richard John Cotton | ▼ Sell | Other | 32,879 | — | 9/11/2023 |
| GLAZER CAPITAL, LLC | ▼ Sell | Open Market | 1,125 | $11K | 5/21/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Spectral AI to Present Burn Wound Imaging Data at ACS 2026
Spectral AI announced it will present data on using artificial intelligence and multi-spectral imaging to assess burn wounds at the ACS Clinical Congress 2026. This event highlights the company's ongoing clinical validation efforts for its medical device technology. The stock is currently trading near its support level, with analyst targets set significantly higher than the recent price range.
Spectral AI to Present Burn Wound Imaging Data at ACS 2026. Spectral AI announced it will present data on using artificial intelligence and multi-spectral imaging to assess burn wounds at the ACS Clinical Congress 2026. This event highlights the company's ongoing clinical validation efforts for its medical device technology. The stock is currently trading near its support level, with analyst targets set significantly higher than the recent price range.